Precigen, Inc. Common Stock

PGENNASDAQ • USD
4.32 USD
↗ 0.03 (0.61%)🟢PRE MARKET (AS OF 07:55 AM EST)
🟢Market: OPEN

Precigen, Inc. Common Stock (PGEN) is currently trading at $4.32. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (29.1%) and a bullish Golden Cross on the moving averages. On the valuation front, PGEN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Nov 18, 2026.

Open?$4.26
High?$4.35
Low?$4.26
Prev. Close?$4.29
Volume?2.1K
Avg. Volume?6.5M
VWAP?$4.31
Rel. Volume?0.00x
Bid / Ask
Bid?$3.63 × 100
Ask?$5.11 × 100
Spread?$1.48
Midpoint?$4.37
Valuation & Ratios
Market Cap?1.5B
Shares Out?358.5M
Float?171.4M
Float %?48.1%
P/E Ratio?62.73
P/B Ratio?18.27
EPS?$0.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Employees
47
Market Cap
1.5B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2013-08-08
Address
20374 SENECA MEADOWS PARKWAY
GERMANTOWN, MD 20876
Phone: 301-556-9900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
0
Momentum?
98
Short Sent.?
16
Piotroski F-Score?6/9Mixed
Altman Z-Score?-5.92Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?26.19%Squeeze Risk
Short Interest?44.9M
Days to Cover?8.6
Free Float171.4M
Avg Daily Volume5.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?5.58Strong
Quick Ratio?4.83Strong
Cash Ratio?0.49Low
Debt/Equity?1.12Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
33/100
P/E?
Peers
100
S&P
8
62.7PRICEY▾
P/B?
Peers
100
S&P
9
18.27HIGH▾
P/S?
Peers
100
S&P
9
9.76HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
3
42.3HIGH▾
EV/Sales?
Peers
100
S&P
10
10.26HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
78
29.1%STRONG▾
ROA?
Peers
50
S&P
79
11.5%STRONG▾
Cash Flow & Enterprise
FCF?$-74316000
Enterprise Value?$1.6B
Fundamentals ratios updated end of day